Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Growth of Term Infants clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Growth of Term Infants: 1 US clinical trial tracked, none currently recruiting.

Growth of Term Infants is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Mead Johnson Nutrition, running 1 of these trials.

Enrollment posture brief

Registry condition growth-of-term-infants

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Growth of Term Infants (this)0%
Open-enrollment share among volume-matched conditions near Growth of Term Infants

Growth of Term Infants has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Growth of Term Infants on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Growth of Term Infants is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Growth of Term Infants records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Control: Marketed routine infant formula Other
1 trials
An investigational infant formula containing a probiotic source Other
1 trials

US sites by state

Facility locations filed on Growth of Term Infants trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Ohio 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Kentucky 1 trials
Indiana 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Growth of Term Infants page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Growth of Term Infants trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Mead Johnson Nutrition sponsors the most Growth of Term Infants trials on record, review their full trial history before evaluating a specific study. See Mead Johnson Nutrition's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Growth of Term Infants condition card totals 1 registered trials; most-linked intervention Control: Marketed routine infant formula; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.